Tumor necrosis factor receptor 2 mRNA in rat models of hypertension

American Journal of Hypertension

Volumn 16, Issue 8, 2003, Pages 685-688

  Lin, Ruby C Y ^a   Schyvens, Chris G ^b   Zhang, Yi ^b   Whitworth, Judith A ^b   Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Australian National University   (Australia)

Author keywords

Adrenocorticotropin induced hypertension; Corticosterone induced hypertension; huTNFR:Fc; Real time quantitative reverse transcriptase PCR; Spontaneously hypertensive rat; Tumor necrosis factor receptor 2 mRNA

Indexed keywords

BETA ACTIN; CORTICOSTERONE; CORTICOTROPIN; ETANERCEPT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PLACEBO; SYNTHACEN DEPOT; TETRACOSACRIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE; GENE EXPRESSION; HYPERTENSION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TNFR2 GENE;

EID: 0041866838     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00916-6     Document Type: Article

References (19)

1. Dörffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR, Scholze J: Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999;34:113-117.
2. Peeters AC, Netea MG, Janssen MC, Kullberg BJ, Van der Meer JW, Thien T: Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001;31:31-36.
3. Glenn CL, Wang WYS, Benjafield AV, Morris BJ: Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 2000;9:1943-1949.
4. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM: TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998;160:943-952.
5. van Greevenbroek MM, van der Kallen CJ, Geurts JM, Janssen RG, Buurman WA, de Bruin TW: Soluble receptors for tumor necrosis factor-alpha (TNF-R p55 and TNF-R p75) in familial combined hyperlipidemia. Atherosclerosis 2000;153:1-8.
6. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-329.
7. Brakebusch C, Varfolomeev EE, Batkin M, Wallach D: Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J Biol Chem 1994;269:32488-32496.
8. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KUS, Whitworth JA: The anti-oxidant Tempol reverses and partially prevents adrenocorticotropic hormone-induced hypertension in the rat. J Hypertens 2003 (In press).
9. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-1561.
10. Anderson JA, Knott AW, Wilson MA, Garrison RN, Sims DE, Edwards MJ: The effect of soluble tumor necrosis factor receptor-II on endotoxin-mediated hemodynamic instability. J Surg Res 1995;58:53-57.
11. DiPetrillo K, Coutermarsh B, Gesek FA: Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol 2003;284:F113-F121.
12. Turner SW, Wen C, Li M, Fraser TB, Whitworth JA: Adrenocorticotropin dose-response relationships in the rat: hemodynamic, metabolic and hormonal effects. J Hyperten 1998;16:593-600.
13. Serazin-Leroy V, Denis-Henriot D, Morot M, de Mazancourt P, Giudicelli Y: Semi-quantitative RT-PCR for comparison of mRNAs in cells with different amounts of housekeeping gene transcripts. Mol Cell Probes 1998;12:283-291.
14. Freeman WM, Walker SJ, Vrana KE: Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999;26:112-125.
15. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A, Heinen E: Housekeeping genes as internal standards: use and limits. J Biotechnol 1999;75:291-295.
16. Suzuki T, Higgins PJ, Crawford DR: Control selection for RNA quantitation. Biotechniques 2000;29:332-337.
17. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL: Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92:1487-1493.
18. Bergman MR, Kao RH, McCune SA, Holycross BJ: Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats. Am J Physiol 1999;71:H543-H550.
19. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM: Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990;67:871-885.